These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34452376)

  • 1. The Interplay between Bluetongue Virus Infections and Adaptive Immunity.
    Rodríguez-Martín D; Louloudes-Lázaro A; Avia M; Martín V; Rojas JM; Sevilla N
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8.
    Sánchez-Cordón PJ; Pérez de Diego AC; Gómez-Villamandos JC; Sánchez-Vizcaíno JM; Pleguezuelos FJ; Garfia B; del Carmen P; Pedrera M
    Vet Microbiol; 2015 May; 177(1-2):95-105. PubMed ID: 25769647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep.
    Bouet-Cararo C; Contreras V; Caruso A; Top S; Szelechowski M; Bergeron C; Viarouge C; Desprat A; Relmy A; Guibert JM; Dubois E; Thiery R; Bréard E; Bertagnoli S; Richardson J; Foucras G; Meyer G; Schwartz-Cornil I; Zientara S; Klonjkowski B
    PLoS One; 2014; 9(11):e111605. PubMed ID: 25364822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific T-cell subsets have a role in anti-viral immunity and pathogenesis but not viral dynamics or onwards vector transmission of an important livestock arbovirus.
    Newbrook K; Khan N; Fisher A; Chong K; Gubbins S; Davies WC; Sanders C; Busquets MG; Cooke L; Corla A; Ashby M; Flannery J; Batten C; Stokes JE; Sanz-Bernardo B; Carpenter S; Moffat K; Darpel KE
    Front Immunol; 2024; 15():1328820. PubMed ID: 38357545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire.
    Rojas JM; Rodríguez-Calvo T; Sevilla N
    Vet Res; 2017 Jun; 48(1):38. PubMed ID: 28662714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.
    Rojas JM; Peña L; Martín V; Sevilla N
    Vet Res; 2014 Mar; 45(1):30. PubMed ID: 24621015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle.
    Ellis JA; Luedke AJ; Davis WC; Wechsler SJ; Mecham JO; Pratt DL; Elliott JD
    Vet Immunol Immunopathol; 1990 Jan; 24(1):49-67. PubMed ID: 2156375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.
    Martín V; Pascual E; Avia M; Peña L; Valcárcel F; Sevilla N
    PLoS One; 2015; 10(11):e0143273. PubMed ID: 26619062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.
    Rodríguez-Calvo T; Rojas JM; Martín V; Sevilla N
    J Virol; 2014 Jan; 88(2):859-67. PubMed ID: 24173228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
    Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
    Mokoena NB; Moetlhoa B; Rutkowska DA; Mamputha S; Dibakwane VS; Tsekoa TL; O'Kennedy MM
    Vaccine; 2019 Sep; 37(41):6068-6075. PubMed ID: 31471154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera.
    Bréard E; Gorlier A; Viarouge C; Donnet F; Sailleau C; Schulz C; Hoffmann B; Comtet L; Beer M; Zientara S; Vitour D
    Transbound Emerg Dis; 2019 Jan; 66(1):537-545. PubMed ID: 30394662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.
    Mohamed DKA; Du J; Gao S; Tian Z; Zhang G; Huang D; Du R; Kang B; Liu G; Luo J; Yin H
    Vet Microbiol; 2018 Jun; 219():40-48. PubMed ID: 29778203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
    Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
    Kochinger S; Renevey N; Hofmann MA; Zimmer G
    Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon α/β receptor knockout mice as a model to study bluetongue virus infection.
    Ortego J; de la Poza F; Marín-López A
    Virus Res; 2014 Mar; 182():35-42. PubMed ID: 24100234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression in sheep induced by cyclophosphamide, bluetongue virus and their combination: Effect on clinical reaction and viremia.
    Chatzinasiou E; Chaintoutis SC; Dovas CI; Papanastassopoulou M; Papadopoulos O
    Microb Pathog; 2017 Mar; 104():318-327. PubMed ID: 28132769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.
    Jiménez-Cabello L; Utrilla-Trigo S; Calvo-Pinilla E; Lorenzo G; Illescas-Amo M; Benavides J; Moreno S; Marín-López A; Nogales A; Ortego J
    Front Immunol; 2024; 15():1440407. PubMed ID: 39072326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.